What Causes High Phenylalanine Besides Classic PKU?
At a Glance
High phenylalanine on a newborn screen does not always mean classic PKU. It can also be caused by mild hyperphenylalaninemia, BH4 deficiency, or DNAJC12 deficiency. Doctors use specialized blood, urine, and genetic tests to pinpoint the exact cause and determine the best long-term treatment.
Hearing that your baby’s newborn screen showed high phenylalanine (Phe) is incredibly stressful, especially when the doctor says it might not be classic PKU. An elevated screening result simply means your baby has hyperphenylalaninemia (higher than normal levels of phenylalanine in the blood) [1]. While classic PKU is one cause, high phenylalanine can also be caused by mild non-PKU hyperphenylalaninemia, BH4 deficiency, or DNAJC12 deficiency [1][2].
Because each of these conditions requires a different long-term treatment approach, your medical team will run specialized tests to pinpoint the exact cause [1][3]. While waiting for these specialized tests to come back, your medical team will monitor your baby and may start a temporary phenylalanine-restricted diet if their Phe levels are high enough to require it. It is crucial that you do not change your baby’s diet or stop feeding them breastmilk or formula unless explicitly instructed by your metabolic doctor.
Mild Hyperphenylalaninemia (Non-PKU HPA)
The most common alternative to classic PKU is mild hyperphenylalaninemia. In this condition, the enzyme that processes phenylalanine works well enough to prevent a massive buildup, but not perfectly. For context, a normal blood phenylalanine level in a baby is typically under 120 µmol/L (about 2 mg/dL) [4].
Babies with mild HPA have elevated phenylalanine levels, but they stay well below the threshold for classic PKU (classic PKU is typically over 1200 µmol/L, while mild HPA is usually under 600 µmol/L) [5][6]. Depending on exactly how high the levels are, babies with mild HPA often require a much less restrictive diet than those with classic PKU. Those with levels under 600 µmol/L may only need regular monitoring rather than lifelong dietary therapy, though your clinic will determine the safest approach for your child [6][7].
Tetrahydrobiopterin (BH4) Deficiency
To break down phenylalanine, the body’s main enzyme needs a “helper molecule” called BH4 (tetrahydrobiopterin) [8]. A BH4 deficiency occurs when the body cannot make or recycle this molecule [9][10].
BH4 is uniquely important because the body also uses it to create crucial neurotransmitters (chemical messengers in the brain) like dopamine and serotonin [8][9]. If a baby has a BH4 deficiency, simply lowering their dietary phenylalanine will not protect their brain, because they will still lack these essential neurotransmitters [11]. Instead, treatment involves replacing the missing BH4 and providing medications that supply the necessary neurotransmitter building blocks [1][11].
DNAJC12 Deficiency
DNAJC12 deficiency is a very rare, recently discovered metabolic condition [12]. DNAJC12 is a “chaperone protein,” meaning its job is to help fold other enzymes into the correct shape so they can function properly [12].
When this chaperone protein is missing or defective, the enzyme that breaks down phenylalanine cannot do its job, leading to elevated Phe levels [12][13]. Like a BH4 deficiency, DNAJC12 deficiency also impacts the production of dopamine and serotonin, which can lead to movement disorders and developmental issues if left untreated [14][12]. Fortunately, this condition is highly treatable. Depending on the severity, treatment often involves a combination of synthetic BH4, neurotransmitter replacements, and sometimes a phenylalanine-restricted diet, allowing children to develop normally when diagnosed early [15][12].
How Doctors Pinpoint the Diagnosis
While waiting for final answers is incredibly stressful, it is standard procedure for clinics to actively monitor your baby while running confirmatory tests to verify the exact cause of the elevated phenylalanine [1]. Since BH4 and DNAJC12 deficiencies are much rarer than classic PKU, doctors systematically rule them out using the following tools:
- Blood Tests for Phenylalanine and Tyrosine: This confirms the newborn screen by measuring exactly how much phenylalanine is in the blood and how it compares to tyrosine (the substance phenylalanine turns into) [1]. These results usually come back within a few days and guide immediate feeding decisions.
- Urinary Pterin Profiling: This is a specialized urine test that measures pterins (byproducts created when the body uses BH4) [10]. Comparing the levels of different pterins is highly effective for identifying or ruling out most BH4 deficiencies [16][17].
- DHPR Activity Testing: Often done alongside pterin profiling on a dried blood spot, this test checks for a specific type of BH4 recycling problem (DHPR deficiency) that urine tests alone might miss [18].
- BH4 Loading Test: During this test, the baby is given a dose of a synthetic BH4 medication [19]. The medical team then watches to see if the baby’s blood phenylalanine levels drop [20]. This helps determine if the baby’s condition responds to BH4 therapy [19][21].
- Genetic Testing: A blood or saliva sample is used to analyze the baby’s DNA. Genetic testing looks for specific variations in the gene that causes PKU (the PAH gene), as well as genes associated with BH4 metabolism and DNAJC12 [1][3]. This can provide a definitive diagnosis and help predict how severe the condition might be [22][23].
While it typically takes a few weeks for advanced test results (like genetics) to return, your clinic will ensure your baby is safe and medically supported during that time based on their blood Phe levels. Once the exact condition is identified, they will lock in the precise long-term treatment protocol to protect your baby’s health and development.
Common questions in this guide
What causes high phenylalanine besides classic PKU?
What is mild hyperphenylalaninemia (HPA)?
Why does BH4 deficiency require different treatment than PKU?
Should I change my baby's diet while waiting for high phenylalanine test results?
How do doctors diagnose the exact cause of high phenylalanine?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What was my baby's exact phenylalanine level on the initial newborn screen and the confirmatory blood test?
- 2.Should I continue my baby's current feeding routine (breastmilk or standard formula) today, or do we need to start a special medical formula immediately while we wait for test results?
- 3.When can we expect the results of the urinary pterin profile and the genetic tests to come back?
- 4.Will we be doing a BH4 loading test, and what will that process look like?
- 5.If the levels are in the 'mild' range, what is our schedule for monitoring them to ensure they stay in a safe zone?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (23)
- 1
The Utility of Genomic Testing for Hyperphenylalaninemia.
Tendi EA, Guarnaccia M, Morello G, Cavallaro S
Journal of clinical medicine 2022; (11(4)) doi:10.3390/jcm11041061.
PMID: 35207333 - 2
Predictive value of fluorometric method and tandem mass spectrometry for hyperphenylalaninemia and its subtypes in China: A systematic review and meta‑analysis.
Shang Z, Xie P, Pan K, et al.
Experimental and therapeutic medicine 2024; (28(1)):278 doi:10.3892/etm.2024.12566.
PMID: 38800050 - 3
Screening and mutation analysis of hyperphenylalaninemia in newborns from Xiamen, China.
Wang X, He Y, Jiang Y, et al.
Clinica chimica acta; international journal of clinical chemistry 2019; (498()):161-166 doi:10.1016/j.cca.2019.08.021.
PMID: 31445982 - 4
The relationship between serum phenylalanine levels, genotype, and developmental assessment test results in non-phenylketonuria mild hyperphenylalaninemia patients.
İlgüy M, Yıldırım GK, Eyüboğlu D, et al.
European journal of pediatrics 2024; (184(1)):99 doi:10.1007/s00431-024-05929-1.
PMID: 39710741 - 5
Neurotransmitters Disorders with Mild Hyperphenylalaninemia: The Ones That Should Not Be Missed.
Thoalnoon OA, Kareem AA, Hammoodi HZ
Archives of Razi Institute 2023; (78(2)):667-673 doi:10.22092/ARI.2022.359480.2431.
PMID: 37396747 - 6
Neonatal phenylalanine wash-out in phenylketonuria.
Porta F, Ponzone A, Spada M
Metabolic brain disease 2020; (35(7)):1225-1229 doi:10.1007/s11011-020-00602-6.
PMID: 32661828 - 7
Factors affecting the success of follow-up and treatment of adults with phenylketonuria diagnosed by newborn screening.
Tandoğan Z, Gedikbaşı A, Yeşil A, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2026; doi:10.1515/jpem-2026-0112.
PMID: 42370601 - 8
Genotypic variants of the tetrahydrobiopterin (BH4) biosynthesis genes in patients with hyperphenylalaninemia from different regions of Iran.
Nezhad SRK, Aligoodarzi PN, Rostami G, et al.
Molecular genetics & genomic medicine 2024; (12(1)):e2294 doi:10.1002/mgg3.2294.
PMID: 37818795 - 9
6-Pyruvoyltetrahydropterin Synthase Deficiency: Review and Report of 28 Arab Subjects.
Almannai M, Felemban R, Saleh MA, et al.
Pediatric neurology 2019; (96()):40-47 doi:10.1016/j.pediatrneurol.2019.02.008.
PMID: 30926181 - 10
Pterin Profiling in Serum, Dried Blood Spot, and Urine Samples Using LC-MS/MS in Patients with Inherited Hyperphenylalaninemia.
Öktem RM, İnci A, Bayrak H, et al.
Molecular syndromology 2024; (15(3)):185-193 doi:10.1159/000535853.
PMID: 38841329 - 11
Identification of an inherited pathogenic DNAJC12 variant in a patient with hyperphenylalalinemia.
Feng Y, Liu S, Tang C, et al.
Clinica chimica acta; international journal of clinical chemistry 2019; (490()):172-175 doi:10.1016/j.cca.2018.09.002.
PMID: 30179615 - 12
DNAJC12 deficiency: A new strategy in the diagnosis of hyperphenylalaninemias.
Blau N, Martinez A, Hoffmann GF, Thöny B
Molecular genetics and metabolism 2018; (123(1)):1-5 doi:10.1016/j.ymgme.2017.11.005.
PMID: 29174366 - 13
Biallelic Mutations in DNAJC12 Cause Hyperphenylalaninemia, Dystonia, and Intellectual Disability.
Anikster Y, Haack TB, Vilboux T, et al.
American journal of human genetics 2017; (100(2)):257-266 doi:10.1016/j.ajhg.2017.01.002.
PMID: 28132689 - 14
DNAJC12 deficiency: Mild hyperphenylalaninemia and neurological impairment in two siblings.
Fino E, Barbato A, Scaturro GM, et al.
Molecular genetics and metabolism reports 2023; (37()):101008 doi:10.1016/j.ymgmr.2023.101008.
PMID: 38053929 - 15
[Analysis of pathogenicity and genotype-phenotype correlation of the c.158G>A variant of phenylalanine hydroxylase gene].
Yang P, Sun Y, Wang X, et al.
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2024; (41(3)):278-283 doi:10.3760/cma.j.cn511374-20210623-00532.
PMID: 38448014 - 16
Newborn screening and genetic features of patients with hyperphenylalaninemia in a southern Chinese population.
Lin Y, Lin W, Su R, et al.
Clinica chimica acta; international journal of clinical chemistry 2022; (535()):13-18 doi:10.1016/j.cca.2022.08.009.
PMID: 35952926 - 17
BH4-deficient hyperphenylalaninemia in Russia.
Gundorova P, Kuznetcova IA, Baydakova GV, et al.
PloS one 2021; (16(4)):e0249608 doi:10.1371/journal.pone.0249608.
PMID: 33822819 - 18
Clinical, Biochemical, and Radiologic Profiles of Filipino Patients with 6-Pyruvoyl-Tetrahydrobiopterin Synthase (6-PTPS) Deficiency and their Neurodevelopmental Outcomes.
de Castro-Hamoy LG, Moral MALA, Calotes-Castillo LV, et al.
Acta medica Philippina 2025; (59(3)):39-44 doi:10.47895/amp.vi0.9439.
PMID: 40151227 - 19
Age-Dependent Variation in Blood Biopterin Peaks Following Oral Tetrahydrobiopterin Administration in Phenylketonuria.
Kitayama K, Sakaguchi T, Nakano N, et al.
Journal of inherited metabolic disease 2026; (49(2)):e70154 doi:10.1002/jimd.70154.
PMID: 41656011 - 20
Early Screening for Tetrahydrobiopterin Responsiveness in Phenylketonuria.
Porta F, Spada M, Ponzone A
Pediatrics 2017; (140(2)) doi:10.1542/peds.2016-1591.
PMID: 28679641 - 21
Sapropterin dihydrochloride treatment in Turkish hyperphenylalaninemic patients under age four.
Ünal Ö, Gökmen-Özel H, Coşkun T, et al.
The Turkish journal of pediatrics 2015; (57(3)):213-8.
PMID: 26701937 - 22
Spectrum of PAH gene mutations and genotype-phenotype correlation in patients with phenylalanine hydroxylase deficiency from Turkey.
Çınar M, Kılıç Yıldırım G, Kocagil S, Çilingir O
Journal of pediatric endocrinology & metabolism : JPEM 2022; (35(5)):639-647 doi:10.1515/jpem-2022-0047.
PMID: 35355500 - 23
Genotype-Phenotype Relationships in Phenylalanine Hydroxylase Deficiency: Functional Annotation-Enhanced Analysis of 23,427 Individuals.
Blau N, Himmelreich N
Genetics in medicine : official journal of the American College of Medical Genetics 2026; 102640 doi:10.1016/j.gim.2026.102640.
PMID: 42423070
This page is for educational purposes only and does not replace professional medical advice. Always follow your metabolic team's feeding instructions and guidance while waiting for confirmatory newborn screening test results.
Get notified when new evidence is published on Phenylketonuria.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.